{"name":"Istituto Superiore di Sanità","slug":"istituto-superiore-di-sanit","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Structured Treatment Interruptions","genericName":"Structured Treatment Interruptions","slug":"structured-treatment-interruptions","indication":"HIV-1 infection","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Melan-A","genericName":"Melan-A","slug":"melan-a","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Structured Treatment Interruptions","genericName":"Structured Treatment Interruptions","slug":"structured-treatment-interruptions","phase":"phase_3","mechanism":"Structured Treatment Interruptions involve temporarily stopping antiretroviral therapy to assess the body's natural ability to control HIV.","indications":["HIV-1 infection"],"catalyst":""},{"name":"Melan-A","genericName":"Melan-A","slug":"melan-a","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNbEozUmtpcXo0UlJKZktIeVp4S2lTdVRTeUl5V1BaYUFGWnB3cW9XOHBRRkEyQkQtRlU3UkluZjhTVzc4bGRKMVpCSWNKRmltTlpLZXhNYTJhcEY1M0JDS0k3WFBKVUlvNnlhUGZEX2hZWnJsZk9JMWo0R0o2UUhVNkpRVFhKYlFJYTZ5cHpxSHVPYXpFTUIwME9ybXpLUWdZN1hOeF80TFhYaDhxd3c?oc=5","date":"2026-03-30","type":"pipeline","source":"European Medical Journal","summary":"First Human Case of Bird Flu Imported in EU - European Medical Journal","headline":"First Human Case of Bird Flu Imported in EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNaVgteXY4ZVVJaDROOWptaHl0UWZHSUZmSEVqbmdLM3ZMU3k2QTJTVVl5OHBDQ2RTYnB2Wi1QV1BkMXdvYlpvVTFPeGREWkRPeWZtTFZIUm9iaVI0YXEydGlJTGNfb0hfbHZHYklxSWVZS0Z1XzV1a19YQkFFWG5qWjd2VzZNbTBpWkFUcjgtNHpiQQ?oc=5","date":"2026-03-03","type":"pipeline","source":"Statista","summary":"Prevalence of obesity among adults in Italy 2008-2023 - Statista","headline":"Prevalence of obesity among adults in Italy 2008-2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPeFViYWZVeUZQa3ZOOWxnanBkRE9YVmpWZ21qVXlWaFNKT2xLQ0pyM1hOU2xGanQ5b2dlWmsxWHhWNGtBaDJtV3ZsekFwVkpZVWxySGFPWWVGT0pDU2RMQjBEYktUVV91TUZSZEhfYjY2UHdRa25BOWdvbWlWQ3Jidl9feUN5WlU0WFJISXNfclFGRmhuQzNF?oc=5","date":"2025-11-24","type":"pipeline","source":"Statista","summary":"Share of caesarean deliveries in Italy 2022, by region - Statista","headline":"Share of caesarean deliveries in Italy 2022, by region","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxONnB2M2UySHN0Y01uaFJsTVpNZkdWaExBX2RpbmN6OFVvUmlMd2NySm93N2JrOHdQSUV1WUlXbm1BQ2p2R3diU2RRWmd3M2xFWFZ0WERNRkw0VFhhcWFEV3VjYW5BVmhNUU94bVBpZkxXdmN2Z193T0FGV2Q0dU8tV09mR1hYWTVES2llampfeFA?oc=5","date":"2025-09-08","type":"pipeline","source":"Frontiers","summary":"Editorial: Recent advances in pharmaceutical analysis: applications and new challenges for the quality of medicines - Frontiers","headline":"Editorial: Recent advances in pharmaceutical analysis: applications and new challenges for the quality of medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOazNRWUtndklTSFBfNV9OUW5RNThfQjM4YmRmYTZIY19ySDFjU2lua3ZISlZhRHhzRDlBVTIxX2JROE1IOHpSQmJUMUVHTEg2QkJ3ZlNER3AzTllETnRZT2c3UnlnMjgxdFlkZzJWcU9iUzVzUWNfQnNxY0FBOW15Y0hVQzB0dU1odE1nQm5kazdwLUZsS2RyVEtCbjcwUjRtX3VScXFoXzY3UkRDNEhwZnphWmxMNldyQl8wTVluTTR0VTQzUk1UQnFMaDN3empYZU5xcVlSSHN3YWg1Zzl1VjFVQnR4VlE?oc=5","date":"2025-04-03","type":"patent","source":"pharmacytimes.com","summary":"The Landscape of Drug Development and the Pharmaceutical Industry in Italy: Challenges, Trends, and the Role of Generics - pharmacytimes.com","headline":"The Landscape of Drug Development and the Pharmaceutical Industry in Italy: Challenges, Trends, and the Role of Generics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1mVzBGM3dNNDBkbUlwaFFMUzIyRWZubE55SHo2TGhOVl9hc3FiX3pSVTFCbGhmZE9XR21aS2U4NzM2S1NkSU8xZzBXczZ6Q3FpRS1RczNlYjZ1QWdUQ2Nn?oc=5","date":"2024-11-15","type":"pipeline","source":"Nature","summary":"A new paradigm for optimized experimental design in cIEF platforms aimed at an accurate robust and reliable mAbs charge-variant assessment - Nature","headline":"A new paradigm for optimized experimental design in cIEF platforms aimed at an accurate robust and reliable mAbs charge-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE40UTlpQ3BFSkR5VGJfeFo2Y3RoQjR3UVBCTTVHR3d5d3NPQ2NXaE41eFRjUVlMOE9zeUhIalFjOFdFSXNpZzh0Um1nR0RUWDh2YlFrN3JYZDRsZnl2YVJV?oc=5","date":"2024-11-03","type":"pipeline","source":"Nature","summary":"Molecular mechanisms at the basis of the protective effect exerted by EPPS on neurodegeneration induced by prefibrillar amyloid oligomers - Nature","headline":"Molecular mechanisms at the basis of the protective effect exerted by EPPS on neurodegeneration induced by prefibrillar ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNbXVCSjdUdGpPam13U0pJU0J1ZzlUdmJ5SEk2dFFJYnAxZFBvcVJSMEFZWHNSRVpaUVRhcTZpbXRoVkJteDVKalA4MEh3aEUzdWFadVd4eURVUld2YzZpM0RSbk0zN1h4TTRwOFkwOEZKaWNSeHBEcTM2SF8tUFB2VWswNGxablJqQXRjTm5oZ0xoMjQ?oc=5","date":"2024-07-03","type":"pipeline","source":"European Medical Journal","summary":"EASL 2024 Interview: Loreta Kondili - European Medical Journal","headline":"EASL 2024 Interview: Loreta Kondili","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBKSlg5b2hFNnNISW1nZHRSQTRNdkFrbFg3Y3E0YnF1cnB4bzQ3ZXlqTDNIWFZfS3g4VkJ1Y2hGNE1qNGVsbmlnSG9ub09EOEZ0MVd3eWtWd2UzY3V1Y1NR?oc=5","date":"2022-06-06","type":"pipeline","source":"Nature","summary":"Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes - Nature","headline":"Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Pl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVjZYUDZtRmpxUXhjN29NV3UtMG9YYVQ1YS0wYTlhNjM5eTJ2ekZGQW5iNW82SjJWS0xDMXZlc3VRamVQcjRHS21YdC14RXRCWlF4X245anVHeFU1ZXdYWFBuV0Q2VTZINVh3MFVrUW92Q2E4S0IxaEo0ZFlhUzJGSjJSNWlhckVQdkdKa3ViUXM0RnB4ekdkZlBYY1dVeUdvWHExMjAwLS1BaFE?oc=5","date":"2019-12-05","type":"pipeline","source":"Open Access Government","summary":"Climate change: Modifying our views on environmental risks - Open Access Government","headline":"Climate change: Modifying our views on environmental risks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9IcjFaOTI3SDVYUzlyWnlWOEVRaHBIajhMT3FIelhUbThnZnh1SmlfWUlJbDVZRnFzRWZZWGpWOVA0RXppU3lYRTZLRzAyTzlscDd5NFk2bTY2YU56d3NuRUxRMzQtN25ZS25DdzhURmhxbXUtTEVmSm9pMzdRaXM?oc=5","date":"2018-09-18","type":"pipeline","source":"Open Access Government","summary":"The European Commission roadmap: Towards a More Comprehensive EU Framework on Endocrine Disruptors - Open Access Government","headline":"The European Commission roadmap: Towards a More Comprehensive EU Framework on Endocrine Disruptors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNdDZVOEtKa1VWMjhaQ05ZS2FvZkdDOWVNNGtaRGxBMk44OUhzdlhfTFJ1c2lhWFp6Rm5vbWd2VENVdENidFJIeTA5dVRjc0xCa1B3N0h6X0tITFIwQ1I4ZnZsTFpDa3B4dDVtRjdXRlhhakNxZ19HV19CQlg5eWt2R0ZLdUF5NHItMDM5OG9rWVZ3NGRFN3YyQlhlb1I?oc=5","date":"2017-10-13","type":"pipeline","source":"Open Access Government","summary":"Mio caro, Human sperm cells, the overlooked sentinel of our living environment - Open Access Government","headline":"Mio caro, Human sperm cells, the overlooked sentinel of our living environment","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}